Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden

BACKGROUND: The long-term safety of proton pump inhibitors (PPIs) is increasingly questioned. The aim of our study was to assess the risk of pancreatic cancer among long-term PPI users in Sweden. METHODS: This population-based nationwide Swedish cohort study including 796,492 adult long-term PPI use...

Descripción completa

Detalles Bibliográficos
Autores principales: Brusselaers, Nele, Sadr-Azodi, Omid, Engstrand, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2019
Materias:
Original Article—Liver, Pancreas, and Biliary Tract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080689/
https://www.ncbi.nlm.nih.gov/pubmed/31811561
http://dx.doi.org/10.1007/s00535-019-01652-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080689/
https://www.ncbi.nlm.nih.gov/pubmed/31811561
http://dx.doi.org/10.1007/s00535-019-01652-z

Ejemplares similares